Bio Net Income Applicable To Common Shares from 2010 to 2026
| TECH Stock | USD 65.25 1.16 1.81% |
Net Income Applicable To Common Shares | First Reported 2000-03-31 | Previous Quarter 70.2 M | Current Value 75.5 M | Quarterly Volatility 19.3 M |
Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 M, Total Revenue of 1.5 B or Gross Profit of 954.3 M, as well as many indicators such as Price To Sales Ratio of 6.86, Dividend Yield of 0.0106 or PTB Ratio of 6.72. Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.
Bio | Net Income Applicable To Common Shares | Build AI portfolio with Bio Stock |
The Net Income Applicable To Common Shares trend for Bio Techne Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Bio Techne is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Bio Techne's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Bio Techne Corp over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Bio Techne's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Techne's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Bio Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 178,970,207 | |
| Geometric Mean | 149,065,023 | |
| Coefficient Of Variation | 56.53 | |
| Mean Deviation | 91,368,009 | |
| Median | 126,042,000 | |
| Standard Deviation | 101,174,200 | |
| Sample Variance | 10236.2T | |
| Range | 317.9M | |
| R-Value | 0.91 | |
| Mean Square Error | 1957.7T | |
| R-Squared | 0.82 | |
| Slope | 18,150,634 | |
| Total Sum of Squares | 163779.5T |
Bio Net Income Applicable To Common Shares History
About Bio Techne Financial Statements
Investors use fundamental indicators, such as Bio Techne's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Bio Techne's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 328.1 M | 344.5 M |
Currently Active Assets on Macroaxis
| VGIAX | Vanguard Growth And | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| ASML | ASML Holding NV |
Check out the analysis of Bio Techne Correlation against competitors. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is there potential for Life Sciences Tools & Services market expansion? Will Bio introduce new products? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.143 | Dividend Share 0.32 | Earnings Share 0.49 | Revenue Per Share | Quarterly Revenue Growth (0.01) |
Understanding Bio Techne Corp requires distinguishing between market price and book value, where the latter reflects Bio's accounting equity. The concept of intrinsic value—what Bio Techne's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Bio Techne's price substantially above or below its fundamental value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Bio Techne's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.